← Back to Clinical Trials
Recruiting NCT07788339

NCT07788339 Keep Social Randomized Controlled Trial for Young Adults With Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07788339
Status Recruiting
Phase —
Sponsor UNC Lineberger Comprehensive Cancer Center
Condition Cancer
Study Type INTERVENTIONAL
Enrollment 395 participants
Start Date 2026-09-15
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 22 Years
Max Age 39 Years
Study Type INTERVENTIONAL
Interventions
Social connectedness intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 395 participants in total. It began in 2026-09-15 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The main purpose of this Keep Social randomized controlled trial is to examine the effectiveness of our social connectedness intervention to improve social and emotional well-being among young adults with cancer. The investigators will conduct a randomized controlled trial with a sample of up to 395 US young adults (ages 22-39) who previous had a cancer diagnosis as an adolescent or young adult (diagnosed at age 15-39).

Eligibility Criteria

Inclusion Criteria: * Are ages 22-39 * Received a cancer diagnosis between ages 15-39 * Use social media * Reside in the United States Exclusion Criteria: * Report high psychosocial health (≥4.5 mean of two mental health quality of life items) * Report being unable to take the study surveys because their schedule will not allow, they are not interested in taking the study surveys, or do not intend to complete the study surveys

Contact & Investigator

Central Contact

Mirian Avendano-Galdamez, BA

✉ Mirian_Avendano_Galdamez@med.unc.edu

📞 984-974-0000

Principal Investigator

Allison Lazard, PhD

PRINCIPAL INVESTIGATOR

UNC Lineberger Comprehensive Cancer Center

Frequently Asked Questions

Who can join the NCT07788339 clinical trial?

This trial is open to participants of all sexes, aged 22 Years or older, up to 39 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07788339 currently recruiting?

Yes, NCT07788339 is actively recruiting participants. Contact the research team at Mirian_Avendano_Galdamez@med.unc.edu for enrollment information.

Where is the NCT07788339 trial being conducted?

This trial is being conducted at Chapel Hill, United States.

Who is sponsoring the NCT07788339 clinical trial?

NCT07788339 is sponsored by UNC Lineberger Comprehensive Cancer Center. The principal investigator is Allison Lazard, PhD at UNC Lineberger Comprehensive Cancer Center. The trial plans to enroll 395 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology